Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Irvingia gabonensis extract, commonly known as African mango, is a botanical extract derived from the seeds of the West African tree *Irvingia gabonensis*. It is primarily utilized as a dietary supplement for weight management and metabolic health. The most clinically studied standardized version is IGOB131. The extract contains active polyphenolic compounds, including ellagic acid and its derivatives. Its mechanism of action involves the modulation of adipogenesis and lipid metabolism by down-regulating the expression of peroxisome proliferator-activated receptor gamma (PPARγ) and leptin genes, while up-regulating adiponectin. Clinical trials have investigated its efficacy in treating obesity, metabolic syndrome, and hyperlipidemia, though evidence quality is often cited as limited due to methodological concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on irvingia gabonensis extract.